home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  CELL SIGNALING, TRANSCRIPTION AND TRANSLATION AS THERAPEUTIC TARGETS  
  May 03, 2001

Cell and Molecular Biology / Anatomy

 
     
  RSL, European Conference Center, Luxembourg
Wednesday, January 30 to Saturday, February 2nd 2002


M A I N T O P I C S

Session 1 : Protein Domains
Session 2 : Bioinformatics in signal transduction and gene expression
Session 3 : Integrin signalling
Session 4 : Signal transduction in Health and disease
Session 5 : Signal Transduction and Inflammation
Session 6 : Signaling pathways
Session 7 : Nutrients regulated gene expression
Session 8 : Apoptosis pathways I
Session 9 : Apoptosis pathways II
Session 10 : Cell cycle control
Session 11 : G proteins
Session 12 : Kinase cascades as therapeutic targets
Session 13 : Transcription factor paradigms
Session 14 : Translational control
 
 
Organized by: Marc Diederich
Invited Speakers: Session 1 : Protein Domains
- Tony Pawson (Mont Sinai Medical Center, Toronto, Canada)
- Michel Véron (CNRS URA 1773 Institut Pasteur, Paris, France)
- Joseph Schlessinger (Department of Pharmacology, New York, USA)

Szession 2 : Bioinformatics in signal transduction and gene expression
- Michael Yaffe (Harvard Medical School, Boston, USA)
- Greg Plowman (Sugen, Inc., Redwood City, USA)

Session 3 : Integrin signalling
- Mark Ginsberg (The Scripps Research Institute, La Jolla, USA
- Walter Birchmeier (Max-Delbück-Center for Molecular Medicine, Berlin, Germany)
- John Collard (The Netherlands Cancer Institute, Amsterdam, The Netherlands)

Session 4 : Signal transduction in Health and disease
- Lorenz Poellinger (Karolinska Institute, Stockholm, Sweden)
- Simon L. Goodman (Merck KgaA, Darmstadt, Germany)
- Donald Ogilvie (AstraZeneca Pharmaceuticals, Macclesfield, United Kingdom)
- Peter Traxler (Novartis Pharmaceuticals, Basel, Switzerland)

Session 5 : Signal Transduction and Inflammation
- Bart Staels (Institut Pasteur, Lille, France)
- Alain Israel (URA CNRS 1773, Institut Pasteur, Paris, France)
- Guy Haegman (Flanders Interuniversity Institute for Biotechnology , Ghent, Belgium)

Session 6 : Signaling pathways
- Mathieu Bollen (Katholieke Universiteit Leuven, Leuven, Belgium)

Session 7 : Nutrients regulated gene expression
- Axel Kahn (Institut Cochin de Génétique Moléculaire, Paris, France)
- Claude Forest (INSERM Unit 530, Meudon, France)
- Barath Aggarwal (The University of Texas M. D. Anderson Cancer Center, Houston, USA)


Session 8 : Apoptosis pathways I
- Moshe Oren (The Weizmann Institute of Science, Rehovot, Israel)
- Guido Kroemer (CNRS, UPR 420, Villejuif, France)
- Suzanne Cory (The Walter and Eliza Hall Institute of Medical Research, Victoria, Australia)
- Peter Krammer (German Cancer Research Center, Heidelberg, Germany)

Session 9 : Apoptosis pathways II
- Vishva M. Dixit (Genentech Inc., South San Francisco, USA)
- Jurg Tschopp (University of Lausanne, Epalinges, Switzerland)
- Martin JS Dyer (Institute of Cancer Research, Sutton, United Kingdom)
- Vincent Bours (Université de Liège, Belgium)

Session 10 : Cell cycle control
- Alvaro Puga (University of Cincinnati Medical Center, Cincinnati, USA)
- Charles J. Sherr (St. Jude Children's Research Hospital, Memphis, USA)
- Tony Hunter (The Salk Institute for Biological Studies, San Diego, USA)

Session 11 : G proteins
- Johannes L. Bos (Utrecht University, Utrecht, The Netherlands)
- Pierre Chardin (IPMC-CNRS UPR 411, Sophia-Antipolis, France)
- Alan Hall (University College London, United Kingdom)

Session 12 : Kinases
- Dario Alessi (University of Dundee, Dundee DD1 5EH, United Kingdom)
- Julian Downward (Imperial Cancer Research Fund, London, United Kingdom)
- Roger J. Davis (Department of Biochemistry and Molecular Biology, Worcester, USA)
- Tony Kong (College of Pharmacy, Chicago, USA)
- Jacques Pousségur (Université de Nice, Nice, France)

Session 13 : Transcription factor paradigms
- Michael Karin (University of California San Diego, La Jolla, USA)
- Dominique Stéhelin (CNRS IFR3, Lille, France)
- Stuart Orkin (Children's Hospital, Boston, USA)
- James Darnell (Memorial Sloan-Kettering Cancer Center, New York, USA)
- Gregg L. Semenza (The Johns Hopkins University School of Medicine, Baltimore, USA

Session 14 : Translational control
- Marylin Kozak (Department of Biochemistry, Piscataway, USA)
- Mathias Hentze (European Molecular Biology Laboratory, Heidelberg, Germany
- Simon Morley (University of Sussex, Brighton, United Kingdom)
 
Deadline for Abstracts: December 30, 2001
 
Registration: Contact : Marc DIEDERICH
RSL/Centre Universitaire de Luxembourg
162A avenue de la Faiencerie
L-1511 Luxembourg (Luxembourg)
Phone : + 352 46 66 44 434
Fax : + 352 46 66 44 438
Email : diederic@cu.lu
E-mail: diederic@cu.lu
 
  Posted by:   Marc Diederich  
Host: ggt.labext.cu.lu
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.